Home › Cambridge biotech buys Pfizer assets and relaunches as Icagen
 

Keywords :   


Cambridge biotech buys Pfizer assets and relaunches as Icagen

2015-07-02 17:16:31| Biotech - Topix.net

A 12-year-old Cambridge biotech that changed its name last year from Caldera Pharmaceuticals to XRpro Sciences relaunched this morning with a third name - one that harkens back to a North Carolina biotech acquired by Pfizer a few years back. Icagen partners with pharmaceutical and biotechnology companies to offer scientific expertise and access to technologies for ion channel and transporter drug discovery and development.

Tags: assets cambridge biotech buys

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11Boeing strike ends as workers back 38% pay rise deal
05.11Tropical Storm Rafael Public Advisory Number 6A
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Graphics
05.11Atlantic Tropical Weather Outlook
05.11Eastern North Pacific Tropical Weather Outlook
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Forecast Discussion Number 6
More »